NASDAQ · LABORATORY APPARATUS & FURNITURE · SMALL CAP
Kewaunee Scientific Corporation KEQU
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$282.0M
▲ 17.3% vs FY2024
EPS · FY25
$3.22
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
13.8%
Net margin · FY25
3.4%
Dividend coverage
-4.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 282.0M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
3 cents of every revenue dollar became profit this year.
Per share
USD 3.22
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
13.8%
Return on equity, FY2025
ROE
Operating margin5.9%
Net margin3.4%
Return on assets5.2%
Each USD of equity produced 14 cents of profit this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 0.00
Share of profit0.0%
Consecutive raises—
Growth
+13.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+8.7%
+13.8%
+8.2%
+7.2%
Net income
+135.3%
+9.7%
+11.6%
EPS, diluted
+134.4%
+8.5%
+10.5%
Dividend / share
−13.1%
−4.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years+3.7%
Change, 10 years+6.7%
The share count grew 4% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 178.3M
total assets, end of FY2025
Total assetsUSD 178.3M
EquityUSD 74.7M
CashUSD 9.9M
Gross debtUSD 20.1M
Net debtUSD 10.1M
Current ratio2.18×
Net debt stands at 14% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Operating income $B
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
3.22
3.83
6.38
0.25
−2.20
−1.33
−1.70
0.55
1.90
1.66
1.42
1.33
1.48
1.17
0.40
0.72
1.39
Dividend / sh $
·
·
·
·
·
·
0.38
0.74
0.66
0.58
0.51
0.47
0.44
0.40
0.40
·
·
Payout %
·
·
·
·
·
−0
−22
133
34
35
36
35
29
34
100
56
27
ROE %
13.8
19.1
40.7
2.0
−15.9
−9.2
−11.0
3.2
11.6
11.1
10.4
10.3
11.9
9.9
3.4
6.0
11.7
Shares out B
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed